IRD – opus genetics, inc. (US:NASDAQ)
Stock Stats
News
Opus Genetics Announces Data Presentations at the 2026 American Society of Cataract and Refractive Surgery Annual Meeting
Opus Genetics Solidifies Leadership Position in Gene Therapy Development for Inherited Retinal Diseases with Strategic Long-Term Financing by Oberland Capital [Yahoo! Finance]
Opus Genetics Solidifies Leadership Position in Gene Therapy Development for Inherited Retinal Diseases with Strategic Long-Term Financing by Oberland Capital
Opus Genetics (IRD) is now covered by Cantor Fitzgerald. They set an "overweight" rating and a $15.00 price target on the stock.
Opus Genetics Named to Fast Company's Annual List of the World's Most Innovative Companies of 2026 [TheStreet.com]
Form 8-K Opus Genetics, Inc. For: Apr 21
Form 144 Opus Genetics, Inc. Filed by: Gagnon Robert E.
Form 144 Opus Genetics, Inc. Filed by: Magrath George
Form 144 Opus Genetics, Inc. Filed by: SCHACHLE JOSEPH K
Form 144 Opus Genetics, Inc. Filed by: YERXA BENJAMIN R
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.